RhD-Negative Blood and Anti-D: What It Means in Pregnancy
Key message: RhD-negative blood is not an illness. Anti-D immunoglobulin prevents the immune system from forming antibodies against…
Key message: RhD-negative blood is not an illness. Anti-D immunoglobulin prevents the immune system from forming antibodies against RhD-positive fetal blood, protecting this and especially future pregnancies from haemolytic disease.
Get urgent help: Heavy bleeding, abdominal trauma, severe pain or reduced movements needs urgent maternity assessment; Anti-D is only one part of care. Tell the team immediately that you are RhD negative after bleeding, trauma or a procedure.
What are RhD and sensitisation?
RhD is a red-cell antigen. An RhD-negative mother may carry an RhD-positive baby. If fetal cells enter maternal blood, the immune system can form anti-D antibodies.
These antibodies can cross the placenta in a later pregnancy and destroy fetal red cells.
What tests are done?
- Maternal blood group and antibody screen early in pregnancy.
- Repeat antibody screening later according to the antenatal pathway.
- Fetal RhD genotyping from maternal blood where an approved service is available.
- Additional antibody levels and fetal monitoring when clinically significant antibodies are detected.
When is routine Anti-D offered?
Unsensitised RhD-negative patients carrying or likely to carry an RhD-positive baby are offered routine antenatal prophylaxis, commonly as one dose around 28–30 weeks or two doses according to the local product and protocol.
Exact timing and dose must follow the maternity service; fetal genotyping may avoid unnecessary injections when the fetus is RhD negative.
Which events may require additional Anti-D?
- Vaginal bleeding at gestations and circumstances defined by the local protocol.
- Abdominal trauma.
- CVS, amniocentesis or another invasive procedure.
- External cephalic version.
- Ectopic pregnancy, miscarriage or pregnancy termination according to gestation and treatment.
- Placental abruption or other suspected fetomaternal bleeding.
What happens after birth?
The baby’s blood group is checked. If the baby is RhD positive, Anti-D is given to an unsensitised RhD-negative mother, usually within 72 hours, with an additional test to estimate a large fetomaternal haemorrhage and adjust dose when needed.
Anti-D is not needed for an RhD-negative baby.
What if anti-D antibodies are already present?
Prophylactic Anti-D cannot remove antibodies once sensitisation has occurred. The pregnancy follows a specialist antibody pathway with serial levels and fetal Doppler for anaemia when indicated.
Other red-cell antibodies can also be important and require tailored care.
Is Anti-D a vaccine or blood transfusion?
It is an immunoglobulin produced from screened donor plasma, not a vaccine and not a transfusion of red cells. As with any injection, local discomfort or a rare allergic reaction can occur.
The product and consent information should be explained.
Does Anti-D affect breastfeeding or future fertility?
Anti-D is compatible with breastfeeding and does not reduce fertility. Its purpose is to protect future RhD-positive pregnancies.
Keep documentation of doses and antibody results.
Frequently asked questions
Is being RhD negative dangerous?
No. The issue is antibody formation when carrying an RhD-positive baby.
Do I need Anti-D if the fetus is RhD negative?
No, when fetal status is reliably confirmed through an approved pathway.
Can I refuse Anti-D?
Yes after informed discussion, but understand the sensitisation risk and future-pregnancy consequences.
Does every early bleed require Anti-D?
Recommendations depend on gestation, amount, recurrence and treatment; follow the current local protocol.
Can Anti-D treat existing antibodies?
No. It prevents sensitisation but does not remove established antibodies.
Your next step
Keep your blood-group and antibody results available. After bleeding, trauma or an invasive procedure, ask promptly whether an extra Anti-D dose and fetomaternal-haemorrhage test are required.
Medical and content review: Dr Mohamed Abdelghany, Obstetrics & Gynecology Specialist, MRCOG (UK), MSc Obstetrics & Gynecology – Kasr Al-Ainy, Cairo University.
Last reviewed: 23 August 2026.
This information is for general education and does not replace individual medical assessment. Severe, sudden or concerning symptoms should not wait for a routine appointment.
